Norden Gregory
SEC-identified person · CIK 1405104 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Praxis Precision Medicines, Inc. PRAX | Director | filed 2020–2026 |
| Royalty Pharma plc RPRX | Director | filed 2020–2026 |
| Zoetis Inc. ZTS | Director | filed 2013–2026 |
| Nanostring Technologies Inc NSTG | Director | filed 2013–2024 |
| Entasis Therapeutics Holdings Inc. [ETTX] | Director | filed 2018–2019 |
| KV Pharmaceutical CO /DE/ kva/kvb | Director | filed 2013–2014 |
| Human Genome Sciences INC HGSI | Director | filed 2011–2012 |
| Wyeth WYE | Sr. VP and CFO | filed 2007–2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.